These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34715953)

  • 1. Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal.
    Silva DF; Silva PD; Torgal A; Braga S; Rocha D; Ochoa C; Oliveira Á; Rocha L; Dias JM; Baldaque I
    Acta Med Port; 2021 Jun; 34(6):484-485. PubMed ID: 34715953
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
    Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis.
    Jones CR; Hamilton FW; Thompson A; Morris TT; Moran E
    J Infect; 2021 Mar; 82(3):e24-e27. PubMed ID: 33271169
    [No Abstract]   [Full Text] [Related]  

  • 8. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
    Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
    Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.
    Shah VP; Hainy CM; Swift MD; Breeher LE; Theel ES; Sampathkumar P
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1532-1534. PubMed ID: 33213552
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
    Rudberg AS; Havervall S; Månberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson AC; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellström C; Bayati S; Bergström S; Pin E; Sjöberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thålin C
    Nat Commun; 2020 Oct; 11(1):5064. PubMed ID: 33033249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
    Stubblefield WB; Talbot HK; Feldstein LR; Tenforde MW; Ur Rasheed MA; Mills L; Lester SN; Freeman B; Thornburg NJ; Jones ID; Ward MJ; Lindsell CJ; Baughman A; Halasa N; Grijalva CG; Rice TW; Patel MM; Self WH
    Clin Infect Dis; 2021 May; 72(9):1645-1648. PubMed ID: 32628750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    Yamamoto S; Tanaka A; Oshiro Y; Ishii M; Ishiwari H; Konishi M; Matsuda K; Ozeki M; Miyo K; Maeda K; Mizoue T; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34044036
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal.
    Canto E Castro L; Pereira AHG; Ribeiro R; Alves C; Veloso L; Vicente V; Alves D; Domingues I; Silva C; Gomes A; Serrano M; Afonso Â; Veldhoen M; de Sousa MJR; de Sousa JGR; de Sousa G; Mota MM; Silva-Santos B; Ribeiro RM
    Emerg Infect Dis; 2021 Nov; 27(11):2878-2881. PubMed ID: 34437830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.